Cargando…
Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value
The incidence of Clostridium difficile infection (CDI) in pediatric patients continues to rise. Most of the pediatric recommendations for CDI treatment are extrapolated from the literature and guidelines for adults. The American Academy of Pediatrics recommends oral metronidazole as the first-line t...
Autores principales: | D’Ostroph, Amanda R, So, Tsz-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655036/ https://www.ncbi.nlm.nih.gov/pubmed/29089778 http://dx.doi.org/10.2147/IDR.S119571 |
Ejemplares similares
-
Fidaxomicin for the Treatment of Clostridium Difficile Infection in the Pediatric Population - Not Quite So Soon Yet
por: Daniels, Tanya, et al.
Publicado: (2011) -
Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
por: Bunnell, Kristen L., et al.
Publicado: (2017) -
The Epidemiology and Economic Burden of Clostridium difficile Infection in Korea
por: Choi, Hyung-Yun, et al.
Publicado: (2015) -
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
por: van Engen, Anke, et al.
Publicado: (2015) -
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection
por: Burton, Hannah E., et al.
Publicado: (2017)